A cluster randomized trial for the implementation of an antibiotic checklist based on validated quality indicators: The AB-checklist

BMC Infectious Diseases

Volumn 15, Issue 1, 2015, Pages

  van Daalen, Frederike V ^a   Prins, Jan M ^a   Opmeer, Brent C ^a   Boermeester, Marja A ^a   Visser, Caroline E ^a   van Hest, Reinier M ^a   Hulscher, Marlies E J L ^b   Geerlings, Suzanne E ^a  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

^b RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Antibiotics; Checklist; Implementation; Quality indicators; Stepped wedge design

Indexed keywords

ANTIBIOTIC AGENT; ANTIINFECTIVE AGENT;

ANTIBIOTIC CHECKLIST; ANTIBIOTIC THERAPY; ARTICLE; BACTERIAL INFECTION; CHECKLIST; CLINICAL EVALUATION; CLINICAL PRACTICE; COMMUNITY ACQUIRED INFECTION; COST BENEFIT ANALYSIS; COST CONTROL; COST EFFECTIVENESS ANALYSIS; DRUG USE; GENERALIZED ESTIMATING EQUATION MODEL; HEALTH CARE PLANNING; HEALTH CARE QUALITY; HOSPITAL INFECTION; HOSPITAL PATIENT; HOSPITAL READMISSION; HUMAN; INTENSIVE CARE UNIT; LENGTH OF STAY; MATHEMATICAL MODEL; MIXED LINEAR MODEL; MORTALITY; NETHERLANDS; OUTCOME ASSESSMENT; PATIENT IDENTIFICATION; PATIENT SELECTION; PROTOCOL COMPLIANCE; RANDOMIZED CONTROLLED TRIAL (TOPIC); SAMPLE SIZE; STEPPED WEDGE STUDY DESIGN; STUDY DESIGN; VALIDATION PROCESS; ADULT; BACTERIAL INFECTIONS; CONTROLLED STUDY; ECONOMICS; FEMALE; METHODOLOGY; ORGANIZATION AND MANAGEMENT; PATIENT CARE PLANNING; PROCEDURES; RANDOMIZED CONTROLLED TRIAL; REGISTER; STANDARDS; STATISTICS AND NUMERICAL DATA;

ADULT; ANTI-BACTERIAL AGENTS; BACTERIAL INFECTIONS; CHECKLIST; COST-BENEFIT ANALYSIS; FEMALE; HEALTH PLAN IMPLEMENTATION; HUMANS; INTENSIVE CARE UNITS; LENGTH OF STAY; NETHERLANDS; PATIENT CARE PLANNING; QUALITY INDICATORS, HEALTH CARE; REGISTRIES; RESEARCH DESIGN;

EID: 84928238378     PISSN: None     EISSN: 14712334     Source Type: Journal    
DOI: 10.1186/s12879-015-0867-2     Document Type: Article

References (19)

1. Goossens H, Ferech M, Vander Stichele R, Elseviers M, ESAC Project Group. Outpatient antibiotic use in Europe and association with resistance: a cross-national database study. Lancet. 2005;365:579-87.
2. Tacconelli E. Antimicrobial use: risk driver of multidrug resistant microorganisms in healthcare settings. Curr Opin Infect Dis. 2009;22:352-8.
3. WHO. Antimicrobial resistance: global report on surveillance 2014. http://www.who.int/drugresistance/documents/surveillancereport/en/ . Accessed April 2014.
4. Schouten JA, Hulscher MEJL, Wollersheim H, Braspenning J, Kullberg BJ, van der Meer JWM, et al. Quality of antibiotic use for lower respiratory tract infections at hospitals: (How) can we measure it? Clin Infect Dis. 2005;41:450-60.
5. Hermanides HS, Hulscher MEJL, Schouten JA, Prins JM, Geerlings SE. Development of quality indicators for the antibiotic treatment of complicated urinary tract infections in the hospital. Clin Infect Dis. 2008;46:703-11.
6. Spoorenberg V, Hulscher ME, Akkermans RP, Prins JM, Geerlings SE. Appropriate antibiotic use for patients with urinary tract infections reduces length of hospital stay. Clin Infect Dis. 2014;58:164-9.
7. van den Bosch CM, Geerlings SE, Natsch S, Wille J, Prins JM, Hulscher ME. Quality indicators to measure appropriate antibiotic use in hospitalized adults. Clin Infect Dis. 2015;60:281-91.
8. Gawande A. The Checklist Manifesto. How to Get Things Right. Metropolitan Books of Henry Holt and Company LLC; 2009.
9. de Vries EN, Prins HA, Crolla RM, den Outer AJ, van Andel G, van Helden SH, et al. Effect of a comprehensive surgical safety system on patient outcomes. N Engl J Med. 2010;363:1928-37.
10. Diaz-Montes TP, Cobb L, Ibeanu OA, Njoku P, Gerardi MA. Introduction of checklists at daily progress notes improves patient care among the gynecological oncology service. J Patient Saf. 2012;8:189-93.
11. Pronovost P, Needham D, Berenholtz S, Sinopoli D, Chu H, Cosgrove S, et al. An intervention to decrease catheter-related bloodstream infections in the ICU. N Engl J Med. 2006;355:2725-32.
12. Fleuren M, Paulussen TGWM, van Dommelen P, van Buuren S. Meetinstrument voor Determinanten van Innovaties (MIDI). Leiden: TNO; 2012. https://www.tno.nl/ .
13. Fleuren M, Wiefferink K, Paulussen T. Determinants of innovation within health care organizations: literature review and Delphi study. Int J Qual Health Care. 2004;16:107-23.
14. Brown. The stepped wedge trial design: a systematic review. BMC Med Res Methodol. 2006;6:54.
15. Sundararajan V, Quan H, Halfon P, Fushimi K, Luthi JC, Burnand B, et al. for the International Methodology Consortium for Coded Health Information (IMECCHI). Cross-National Comparative Performance of Three Versions of the ICD-10 Charlson Index. Med Care. 2007;45:1210-5.
16. Quan H, Sundararajan V, Halfon P, Fong A, Burnand B, Luthi JC, et al. Coding algorithms for defining comorbidities in ICD-9-CM and ICD-10 administrative data. Med Care. 2005;43:1130-9.
17. Subbe CP, Kruger M, Rutherford P, Gemmel L. Validation of a modified early warning score in medical admissions. Q J Med. 2001;94:521-6.
18. Hakkaart- van Roijen L, Tan SS, Bouwmans CAM. Medical Technology Assessment Institute. Handleiding voor kostenonderzoek - Methoden en standaard kostprijzen voor economische evaluaties in de gezondheidszorg. College voor zorgverzekering. 2010. http://www.zinl.nl .
19. Mauskopf JA, Sullivan SD, Annemans L, Caro J, Mullins CD, Nuijten M, et al. Principles of good practice for budget impact analysis: report of the ISPOR Task Force on good research practices-budget impact analysis. Value Health. 2007;10:336-47.